7 analysts have expressed a variety of opinions on Omega Healthcare Invts (NYSE:OHI) over the past quarter, offering a diverse set of opinions from bullish to bearish.
The following table encapsulates their recent ratings, offering a glimpse into the evolving sentiments over the past 30 days and comparing them to the preceding months.
| Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
|---|---|---|---|---|---|
| Total Ratings | 1 | 1 | 5 | 0 | 0 |
| Last 30D | 0 | 0 | 1 | 0 | 0 |
| 1M Ago | 0 | 1 | 2 | 0 | 0 |
| 2M Ago | 1 | 0 | 2 | 0 | 0 |
| 3M Ago | 0 | 0 | 0 | 0 | 0 |
In the assessment of 12-month price targets, analysts unveil insights for Omega Healthcare Invts, presenting an average target of $48.0, a high estimate of $52.00, and a low estimate of $45.00. Surpassing the previous average price target of $46.86, the current average has increased by 2.43%.

Analyzing Analyst Ratings: A Detailed Breakdown
A clear picture of Omega Healthcare Invts's perception among financial experts is painted with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
| Analyst | Analyst Firm | Action Taken | Rating | Current Price Target | Prior Price Target |
|---|---|---|---|---|---|
| Michael Lewis | Truist Securities | Raises | Hold | $48.00 | $46.00 |
| Nicholas Yulico | Scotiabank | Raises | Sector Perform | $48.00 | $45.00 |
| Michael Carroll | RBC Capital | Raises | Sector Perform | $47.00 | $44.00 |
| Richard Anderson | Cantor Fitzgerald | Raises | Overweight | $52.00 | $50.00 |
| John Kilichowski | Wells Fargo | Lowers | Equal-Weight | $45.00 | $48.00 |
| Juan Sanabria | BMO Capital | Maintains | Market Perform | $45.00 | $45.00 |
| Michael Goldsmith | UBS | Raises | Buy | $51.00 | $50.00 |
Key Insights:
- Action Taken: Responding to changing market dynamics and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their response to recent developments related to Omega Healthcare Invts. This offers insight into analysts' perspectives on the current state of the company.
- Rating: Offering insights into predictions, analysts assign qualitative values, from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Omega Healthcare Invts compared to the broader market.
- Price Targets: Gaining insights, analysts provide estimates for the future value of Omega Healthcare Invts's stock. This comparison reveals trends in analysts' expectations over time.
Understanding these analyst evaluations alongside key financial indicators can offer valuable insights into Omega Healthcare Invts's market standing. Stay informed and make well-considered decisions with our Ratings Table.
Stay up to date on Omega Healthcare Invts analyst ratings.
Unveiling the Story Behind Omega Healthcare Invts
Omega Healthcare Investors Inc is a real estate investment trust that invests in healthcare-related real estate properties located in the United States (U.S.), the United Kingdom (U.K.), and Canada. The company's objective is to provide attractive returns to investors while serving as the preferred capital partner to its third-party healthcare operating companies and affiliates, as well as other third-party healthcare operators, allowing them to focus on delivering a high level of care to their resident patients. Omega's investment portfolio mainly consists of skilled nursing facilities, assisted living facilities (ALFs), including care homes in the U.K., independent living facilities, rehabilitation and acute care facilities, and continuing care retirement communities.
Omega Healthcare Invts: Delving into Financials
Market Capitalization Analysis: Reflecting a smaller scale, the company's market capitalization is positioned below industry averages. This could be attributed to factors such as growth expectations or operational capacity.
Revenue Growth: Omega Healthcare Invts's revenue growth over a period of 3M has been noteworthy. As of 31 December, 2025, the company achieved a revenue growth rate of approximately 2.45%. This indicates a substantial increase in the company's top-line earnings. As compared to competitors, the company encountered difficulties, with a growth rate lower than the average among peers in the Real Estate sector.
Net Margin: Omega Healthcare Invts's net margin is impressive, surpassing industry averages. With a net margin of 51.64%, the company demonstrates strong profitability and effective cost management.
Return on Equity (ROE): Omega Healthcare Invts's financial strength is reflected in its exceptional ROE, which exceeds industry averages. With a remarkable ROE of 3.23%, the company showcases efficient use of equity capital and strong financial health.
Return on Assets (ROA): Omega Healthcare Invts's financial strength is reflected in its exceptional ROA, which exceeds industry averages. With a remarkable ROA of 1.6%, the company showcases efficient use of assets and strong financial health.
Debt Management: Omega Healthcare Invts's debt-to-equity ratio is below the industry average. With a ratio of 0.82, the company relies less on debt financing, maintaining a healthier balance between debt and equity, which can be viewed positively by investors.
Analyst Ratings: Simplified
Within the domain of banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their work involves attending company conference calls and meetings, researching company financial statements, and communicating with insiders to publish "analyst ratings" for stocks. Analysts typically assess and rate each stock once per quarter.
Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Login to comment